5.4 COVID-19 Immunization

Clinical Practice Guideline

Mitigating Risks at Multi-Product Immunization Clinics

COVID-19 Vaccines – Storage and Handling

COVID-19 Vaccines Approved for Use in Canada: mRNA vaccines

NACI Statement- Recommendations on the use of COVID-19 vaccines

COVID-19 Moderna Vaccine Quick Reference for Immunizers

COVID-19  Pfizer Vaccine Quick Reference for Immunizers

Memo: Moderna Product Updates (April 3, 2023)

Covid Vaccine Monographs

• Pfizer-BioNTech COVID-19 Vaccine Product Monograph (Comirnaty™)
• Pfizer-BioNTech Bivalent BA.4/5 COVID-19 Vaccine Product Monograph (ComirnatyTM)
• Moderna COVID-19 Bivalent Vaccine Product Monograph (SPIKEVAX™)
• Moderna COVID-19 Vaccine Product Monograph (Spikevax™)
• AstraZeneca COVID-19 Vaccine Product Monograph (Vaxzevria™)
• COVISHIELD COVID-19 Vaccine Product Monograph
• Janssen (Johnson & Johnson) COVID-19 Vaccine Product Monograph
• Novavax COVID-19 Vaccine Product Monograph (Nuvaxovid™)

COVID-19 Vaccine Resources and Forms

Training

• COVID-19 Immunization Training Module for Immunizers

Manitoba Health Eligibility Criteria

COVID Vaccines for Youth

Informed Consent Process and Consent Documentation Requirements, Standard Operating Procedures, Shared Health

Obtaining Consent for Minors Presenting to COVID-19 Immunization Clinics, Standard Operating Procedures, Shared Health

Information for Health Care Professionals

Back to Section 05 – Population Public Health Program Specific Information

Back to Table of Contents